NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PACS Group, Inc. ("PACS" or the "Company") (NYSE:PACS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PACS and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. ("Barnes & Noble" or the "Company") (NYSE:BNED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Barnes & Noble
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. ("Praxis" or the "Company") (NASDAQ:PRAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Praxis and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Six Flags Entertainment Corporation ("Six Flags" or the "Company") (NYSE:FUN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Six Flags and certain of
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation ("Redwire" or the "Company") (NYSE:RDW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Redwire and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Limited ("EHang" or the "Company") (NASDAQ:EH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether EHang and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE:NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Lockheed Martin Corporation ("Lockheed" or the "Company") (NYSE:LMT).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. ("Fiserv" or the "Company") (NYSE:FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / September 12, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX) and certain officers. The class action, filed in the United States District Court for the Southern District of Texas, and docketed under 25-cv-